Wellcome Trust launches investment wing


The Wellcome Trust has provided £200 million to launch an investment company that aims to support innovative healthcare businesses with the potential to transform the markets in which they operate.

The investment company, plans for which were revealed in March 2012, will operate as ‘Syncona’ and look to make investments in the £1–20 million range as a majority investor or as part of a syndicate.

Syncona chief executive Martin Murphy said: ‘We expect to play our part in building successful businesses based upon innovation within the life science and healthcare industry. We very much look forward to working with entrepreneurs, leading academics and inventors to build success stories in the UK, Europe and beyond.’

The Wellcome Trust is one of the largest charitable foundations in the world, spending £600 million per year to support biomedical research and the medical humanities.


Related Content

Wellcome Trust to enforce open access rules

28 June 2012 News and Analysis

news image

UK charitable foundation will cut the grants of scientists who do not make their research freely available

Wellcome Trust announces new head

1 May 2013 News and Analysis

news image

Jeremy Farrar to join the organisation on 1 October

Most Read

Antimicrobial resistance will kill 300 million by 2050 without action

16 December 2014 News and Analysis

news image

UK report says resistance will cost global economy $100 trillion

Cutting edge chemistry in 2014

10 December 2014 Research

news image

We take a look back at the year's most interesting chemical science stories

Most Commented

Smart skin for prosthetic limbs senses heat and touch

12 December 2014 Research

news image

Ultra-thin plastic skin can bend and flex without affecting the skin's ability to detect stimuli

Chemistry behind the ‘blue man’ unlocked

1 November 2012 Research

news image

Biochemical model suggests that silver ions, not nanoparticles, cause a rare skin complaint